nei THIS MONTH IN
PSYCHOPHARMACOLOGY
Browsing articles in "Sleep"

 

Use of Benzodiazepines or Z-drugs Not Associated With Subsequent Dementia
May 19, 2020   

Benzodiazepines and Z-drugs are indicated for treatment of affective disorders and insomnia. Due to cognitive side effects of these treatments, their use has been investigated as risk factors for dementia. However, previous investigations have yielded conflicting results...
 Continue reading (Members only)
Mental Health Outcomes Among Health Care Workers Exposed to Coronavirus
April 9, 2020   

With the rising rates of COVID-19 (i.e., severe acute respiratory syndrome coronavirus 2) infection and hospitalization across the world, frontline health care workers will continue to face an overwhelming workload throughout the course of this pandemic. This workload, along with the depletion of personal protection equipment, widespread media coverage, lack of specific drugs and feelings of being inadequately supported may contribute to adverse psychological reactions...
 Continue reading
Morning Blue Light May Aid Sleep and Recovery in Mild Traumatic Brain Injury
February 5, 2020   

Circadian rhythms and adequate sleep are essential to cognitive functioning. Pulses of blue light administered in the morning can re-entrain circadian rhythms and improve sleep difficulties. In a recent double-blind, placebo-controlled study of 32 adult patients with mild traumatic brain injury...
 Continue reading
FDA Approves Lemborexant for Insomnia
January 9, 2020   

Although the exact reason is unknown, sleep is an essential component of both physical and mental health. Unfortunately, approximately 30% of adults suffer from insomnia -the inability to attain or maintain sleep despite adequate opportunity. Not only do insomnia sufferers have...
 Continue reading (Members only)
Reducing Suicidal Ideation Through Insomnia Treatment (REST-IT): A Randomized Clinical Trial
October 25, 2019   

A recent 8-week three site double-blind placebo-controlled parallel-group randomized controlled trial was conducted to test whether specific treatment of insomnia...
 Continue reading (Members only)
New Medication Approved For Excessive Daytime Sleepiness in Narcolepsy
August 26, 2019   

Narcolepsy is a disorder of hypersomnolence in which the patient experiences intrusion of sleep during periods of wakefulness; it is often accompanied by excessive daytime sleepiness. On August 14, 2019, the FDA approved the ...
 Continue reading (Members only)
Remember to Sleep: Circadian Function in Alzheimer's Disease
July 2, 2019   

Alzheimer's disease affects approximately 44 million individuals worldwide. This age-related disease is characterized by accumulation of extracellular plaques composed of beta-amyloid protein, intracellular neurofibrillary tangles composed of hyperphosporylated tau protein, severe neuronal loss, and aggressive neuroinflammation. There is currently...
 Continue reading (Members only)
FDA Requires Stronger Warnings for Common Insomnia Medications
May 6, 2019   

The US Food and Drug Administration (FDA) is adding a boxed warning to certain prescription insomnia medication following reports of injury and death resulting from sleepwalking, sleep driving, and engaging in other activities while not fully awake after taking these medicines. ...
 Continue reading
FDA Approves New Cranial Electrotherapy Stimulator—Integrated Into a Stereo Headset
April 11, 2019   

The Food and Drug Administration (FDA) has approved a new cranial electrotherapy stimulator for treatment of anxiety, depression, and insomnia. The device, Cervella, is operated using...
 Continue reading (Members only)
To Sleep, Perchance to Learn
February 16, 2017   

Two recent studies in mice suggests that sleep may have much to do with preparing the brain for learning...
 Continue reading (Members only)
123
Top of Page